139 related articles for article (PubMed ID: 22740875)
1. Expression of ERα36 in gastric cancer samples and their matched normal tissues.
Wang J; Li J; Fang R; Xie S; Wang L; Xu C
Oncol Lett; 2012 Jan; 3(1):172-175. PubMed ID: 22740875
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of ERα66 and its novel variant isoform ERα36 in lactotroph pituitary adenomas and associations with clinicopathological characteristics.
Mahboobifard F; Bidari-Zerehpoosh F; Davoudi Z; Panahi M; Dargahi L; Pourgholami MH; Sharifi G; Izadi N; Jorjani M
Pituitary; 2020 Jun; 23(3):232-245. PubMed ID: 32026205
[TBL] [Abstract][Full Text] [Related]
4. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
[TBL] [Abstract][Full Text] [Related]
5. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.
Chamard-Jovenin C; Jung AC; Chesnel A; Abecassis J; Flament S; Ledrappier S; Macabre C; Boukhobza T; Dumond H
BMC Syst Biol; 2015 Jun; 9():28. PubMed ID: 26080803
[TBL] [Abstract][Full Text] [Related]
6. The elevated level of ERα36 is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma.
Zhang S; Qiu C; Wang L; Liu Q; Du J
Steroids; 2014 Sep; 87():39-45. PubMed ID: 24928730
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.
Maczis MA; Maceyka M; Waters MR; Newton J; Singh M; Rigsby MF; Turner TH; Alzubi MA; Harrell JC; Milstien S; Spiegel S
J Lipid Res; 2018 Dec; 59(12):2297-2307. PubMed ID: 30315000
[TBL] [Abstract][Full Text] [Related]
8. The role of ERα36 in cell type-specific functions of estrogen and cancer development.
Mahboobifard F; Dargahi L; Jorjani M; Ramezani Tehrani F; Pourgholami MH
Pharmacol Res; 2021 Jan; 163():105307. PubMed ID: 33246174
[TBL] [Abstract][Full Text] [Related]
9. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
10. Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
Zheng Y; Zhang J; Xu ZZ; Sheng JM; Zhang XC; Wang HH; Teng XD; Liu XJ; Cao J; Teng LS
J Zhejiang Univ Sci B; 2010 Feb; 11(2):144-50. PubMed ID: 20104649
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
[TBL] [Abstract][Full Text] [Related]
12. The Role of ERα36 in Development and Tumor Malignancy.
Thiebaut C; Konan HP; Guerquin MJ; Chesnel A; Livera G; Le Romancer M; Dumond H
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526980
[TBL] [Abstract][Full Text] [Related]
13. Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression.
Thiebaut C; Chamard-Jovenin C; Chesnel A; Morel C; Djermoune EH; Boukhobza T; Dumond H
PLoS One; 2017; 12(3):e0173931. PubMed ID: 28301550
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Biological Significance of
Nagel A; Szade J; Iliszko M; Elzanowska J; Welnicka-Jaskiewicz M; Skokowski J; Stasilojc G; Bigda J; Sadej R; Zaczek A; Markiewicz A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995757
[TBL] [Abstract][Full Text] [Related]
15. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression.
Miceli V; Cocciadiferro L; Fregapane M; Zarcone M; Montalto G; Polito LM; Agostara B; Granata OM; Carruba G
OMICS; 2011 May; 15(5):313-7. PubMed ID: 21348637
[TBL] [Abstract][Full Text] [Related]
16. ERα36, a variant of estrogen receptor α, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells.
Yan Y; Yu L; Castro L; Dixon D
PLoS One; 2017; 12(10):e0186078. PubMed ID: 29020039
[TBL] [Abstract][Full Text] [Related]
17. GRP78 positively regulates estrogen‑stimulated cell growth mediated by ER‑α36 in gastric cancer cells.
Fu Z; Wang X; Zhou H; Li Y; Chen Y; Wang Z; Liu L
Mol Med Rep; 2017 Dec; 16(6):8329-8334. PubMed ID: 28983626
[TBL] [Abstract][Full Text] [Related]
18. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
19. A Role for Estrogen Receptor alpha36 in Cancer Progression.
Pagano MT; Ortona E; Dupuis ML
Front Endocrinol (Lausanne); 2020; 11():506. PubMed ID: 32849292
[TBL] [Abstract][Full Text] [Related]
20. Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required.
Mansouri S; Farahmand L; Teymourzadeh A; Majidzadeh-A K
Curr Cancer Drug Targets; 2018; 18(7):668-676. PubMed ID: 28786348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
